FDA is poised to pull Ocali­va as ad­comm doc­u­ments ques­tion post-ap­proval study re­sults

8 months ago
Pharma
FDA+

FDA drafts new strat­e­gy to boost the use of ad­vanced man­u­fac­tur­ing tech

8 months ago
FDA+
Manufacturing

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

8 months ago
R&D

Xen­cor’s $175M of­fer­ing; Virid­i­an to raise $150M

8 months ago
News Briefing

Sanofi opens ‘world first’ mod­u­lar vac­cines and bi­o­log­ics fac­to­ry in France 

8 months ago
Manufacturing

In­novent Bi­o­log­ics high­lights sub­group of lung can­cer pa­tients in ear­ly-stage study of bis­pe­cif­ic

8 months ago
R&D

For­mer Ver­i­ly ex­ecs launch ef­fort to trans­form clin­i­cal tri­als

8 months ago
People
Financing

Sanofi, Re­gen­eron prep an­oth­er FDA sub­mis­sion for Dupix­ent, this time for a rare skin con­di­tion

8 months ago
R&D

Pan­Tera rais­es €93M to ‘rad­i­cal­ly im­prove sup­ply’ of ac­tini­um for ra­dio­ther­a­peu­tics 

8 months ago
Financing
Manufacturing

Novo's oral amy­cretin could lead to more weight loss be­yond 12 weeks, ac­cord­ing to ear­ly-stage tri­al

8 months ago
R&D

Ra­di­ant Bio snags $35M for an­ti­body plat­form, with GSK and Re­gen­eron part­ner­ships

8 months ago
Financing
Startups

GSK dis­con­tin­ues her­pes ther­a­peu­tic vac­cine af­ter Phase 2 dis­ap­point­ment

8 months ago
R&D

Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win

8 months ago
R&D
FDA+

Bridge­Bio ends de­vel­op­ment of gene ther­a­py for adren­al gland dis­or­der

8 months ago
R&D
Cell/Gene Tx

Adicet fol­lows oth­er cell ther­a­py biotechs in au­toim­mune piv­ot

8 months ago
R&D
Pharma

Cor­rect­ed: Op­tum’s biosim­i­lar busi­ness to go af­ter brand-name Hu­mi­ra, Ste­lara in 2025

8 months ago
Pharma
Health Tech

Gilead part­ners with AI start­up Gen­e­sis Ther­a­peu­tics to make small mol­e­cule drugs

8 months ago
Deals
AI

Con­gress spars over whether the Biose­cure Act is an over­due crack­down or a rushed witch hunt

8 months ago
China
FDA+

FDA sends warn­ing let­ter to In­di­an drug­mak­er af­ter find­ing glass in in­jec­tions 

8 months ago
FDA+
Manufacturing

Lil­ly's week­ly in­sulin hits pri­ma­ry end­points in two more late-stage di­a­betes stud­ies

8 months ago
R&D
Pharma

Roche's dual GLP-1/GIP re­sults show promis­ing weight loss, but al­so high rates of vom­it­ing

8 months ago
R&D
Pharma

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

8 months ago
Startups
R&D

GSK to shut down UK an­tibi­ot­ic fa­cil­i­ty fol­low­ing end of San­doz con­tract

8 months ago
Pharma
Manufacturing

Io­n­is’ $500M of­fer­ing; Terns aims to raise $125M 

8 months ago
News Briefing
First page Previous page 9899100101102103104 Next page Last page
A service from the Financial Times